retatrutide trial update october 2025 This is exciting. 👀 The TRIUMPH-4 results for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far beyond Retatrutide—A Game Changer in Obesity
Description
Full breakdown: | 15 comments on LinkedIn
Personalized treatment, medical supervision & proven results.
These medications are becoming popular but they work best when combined with a healthy lifestyle.
Body Composition
Clinical trials testing GLP-1 receptor agonists in patients with AD or PD have been conducted and have shown first successes, serving as proof of concept that activating GLP-1 receptor is a sensible strategy to treat AD/PD
